SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001615774-16-006981
Filing Date
2016-08-29
Accepted
2016-08-29 15:15:19
Documents
8
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A s103999_10qa.htm 10-Q/A 18924
2 EXHIBIT 10.1 s103999_ex10-1.htm EX-10.1 196212
3 EXHIBIT 10.2 s103999_ex10-2.htm EX-10.2 135481
4 EXHIBIT 31.1 s103999_ex31-1.htm EX-31.1 9313
5 EXHIBIT 31.2 s103999_ex31-2.htm EX-31.2 9319
6 GRAPHIC tlogo1.jpg GRAPHIC 11915
7 GRAPHIC tlogo12.jpg GRAPHIC 12725
8 GRAPHIC tlogo24.jpg GRAPHIC 11921
  Complete submission text file 0001615774-16-006981.txt   421063
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-27072 | Film No.: 161857552
SIC: 2836 Biological Products, (No Diagnostic Substances)